S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone

NCT00410813 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

85

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer
Metastatic Cancer

Interventions

DRUG: dasatinib

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]